3 papers reviewed
Uterine Fibroids — Nutritional & Non-Surgical Approaches
2024 · review · 1 of 3
The Potential of Vitamin D and Epigallocatechin Gallate (EGCG) for the Treatment of Uterine Fibroids: Evidence From In Vitro to Clinical Studies
— · Johns Hopkins / Fertility and Sterility
In a randomized controlled trial, green tea extract (EGCG) reduced total fibroid volume by 32.6% versus a 24.3% increase on placebo, with 32.4% reduction in symptom severity and 18.5% improvement in quality of life. Combined vitamin D and EGCG shows synergistic preliminary results.
Read the paper ↗2021 · pilot study · 2 of 3
Vitamin D and green tea extracts for the treatment of uterine fibroids in late reproductive life: a pilot, prospective, daily-diary based study
— · Gynecological Endocrinology
Prospective pilot supporting combined vitamin D and green tea extract for fibroid-related symptoms in late reproductive years.
Read the paper ↗2023 · RCT · 3 of 3
Assessing the Hepatic Safety of Epigallocatechin Gallate (EGCG) in Reproductive-Aged Women
— · Nutrients / PMC
Essential safety counterpart: concentrated EGCG extracts carry a documented risk of hepatotoxicity, distinct from drinking green tea. This study characterises hepatic safety in reproductive-aged women and supports monitoring rather than unsupervised high-dose use.
Read the paper ↗A paper's presence documents the evidence reviewed; it does not mean Filia endorses every intervention or conclusion.